Rx Networks Introduces TruePoint | FOCUS: Unlocking Instantaneous Centimeter-Level Accuracy for the Masses
Leading GNSS data services provider, Rx Networks, unveils TruePoint | FOCUS, a high-precision cloud-based GNSS correction service delivering instantaneous centimeter-level accuracy across a wide range of applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250408494006/en/
Rx Networks launches TruePoint | FOCUS: Instantaneous Centimeter-Level Accuracy, Effortless setup, Unmatched reliability, Designed for any scale.
TruePoint | FOCUS is designed to meet the demands of applications that require real-time precision without compromise. It supports both RTK (OSR) and PPP-RTK (SSR) modes to deliver flexibility and performance across a range of devices and use cases. The service empowers GNSS receivers with centimeter-level positioning accuracy, enabling a wide array of high-precision use cases in industries such as micro-mobility, smart agriculture, robotics, drones, IoT, and machine control.
The RTK mode is fully hardware-agnostic and compatible with all RTK-capable GNSS receivers, removing the limitations imposed by proprietary ecosystems. TruePoint | FOCUS ensures effortless integration through standard correction protocols like RTCM v3, and supports access via NTRIP, allowing for rapid deployment and minimal integration effort.
In PPP-RTK mode, users can benefit from advanced SSR-based delivery, achieving high-accuracy positioning with optimized bandwidth. TruePoint | FOCUS also supports more GNSS signals than most competing solutions, delivering enhanced resilience and performance in challenging environments.
“Precision means nothing without reliability,” said John Carley, CEO at Rx Networks. “TruePoint | FOCUS is built on the same ultra-reliable server architecture that powers our Location.io service, which supports critical applications worldwide, ensuring our customers get the accuracy they need, every time.”
TruePoint | FOCUS delivers consistent centimeter-level accuracy with a 99.9% SLA. Its seamless coverage and real-time performance make it ideal for companies operating across North America, Europe, China, and beyond. The correction stream is configurable and includes all available signals across GPS, Galileo, and BeiDou constellations, making TruePoint | FOCUS one of the most comprehensive GNSS correction services on the market.
“With this launch, Rx Networks expands the TruePoint portfolio to include LITE, REACH, and now FOCUS,” said Ali Soliman, VP of Sales and Marketing at Rx Networks. “Together, these offerings address a wide range of use cases balancing accuracy, coverage, cost and hardware compatibility to support the next generation of GNSS applications.”
TruePoint | FOCUS is available today for trial in both RTK and PPP-RTK modes across the covered regions, with more new areas on the roadmap. Users can sign up for a complimentary 30-day trial license at http://www.rxnetworks.com/request-a-free-trial. For further inquiries, contact sales@rxnetworks.com.
About Rx Networks Inc.
Rx Networks is a Canadian company that provides reliable, timely, and relevant location assistance and correction data that improves the GNSS experience and strengthen the connection between people. Billions of devices benefit from Rx Networks GNSS data services every day.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250408494006/en/
Contacts
Rx Networks Inc.
Ali Soliman
VP of Sales and Marketing
asoliman@rxnetworks.com
+1 408 734 6551
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lineage Expands Nordic Presence with Strategic Acquisition of Permanor AS in Norway6.5.2025 10:00:00 EEST | Press release
Lineage, Inc. (NASDAQ: LINE) (“Lineage”), the world’s largest global temperature-controlled warehouse REIT, today announced that it has completed the acquisition of Permanor AS, a leading provider of cold storage and logistics solutions in Norway. The acquisition includes Permanor AS’s operations and property in Haugesund and Brumunddal, further strengthening Lineage’s footprint in the Nordics market and enhancing its ability to serve the region’s growing food supply chain. Permanor AS specializes in freezing, thawing, storage, and logistics services, primarily catering to the meat manufacturing industry, alongside handling baked goods and other food commodities. The Haugesund site, originally built in 2009 and expanded in 2018, is strategically positioned near key harbors in Stavanger, Haugesund, and Bergen, supporting efficient distribution. The Brumunddal site, located just an hour north of Oslo, serves as a vital hub for Norwegian food logistics. The acquisition aligns with Lineage
Agendia to Present FLEX Study Data on Impact of BluePrint® at ESMO Breast Cancer 20256.5.2025 09:00:00 EEST | Press release
Agendia®, Inc., today announced that new data from its ongoing FLEX Study will be presented at the upcoming ESMO BreastCancer 2025 congress taking place May 14-17 in both Munich, Germany and virtually. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505212759/en/ The FLEX Study (NCT03053193) is a prospective real-world evidence, observational breast cancer study designed to correlate whole transcriptome gene expression in early-stage breast cancer with clinical outcomes, and to evaluate how genomic insights can inform treatment decisions in early-stage breast cancer. In this analysis, researchers examined the impact of BluePrint, Agendia’s 80-gene molecular subtyping assay, on pathological complete response (pCR) rates and chemotherapy (CT) decision-making in patients with hormone receptor-positive (HR+), HER2-negative tumors classified as High Risk by MammaPrint. BluePrint further stratified these tumors into Basal or Lum
Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x6.5.2025 07:15:00 EEST | Press release
Owkin, a leading agentic AI company, has launched K Navigator, an AI-powered research co-pilot designed to revolutionize biomedical science. K Navigator is an agentic playground where researchers can explore, refine, and validate hypotheses, accelerating the quality and pace of their discoveries. With K Navigator, Owkin moves closer to its vision of developing the world’s first Biological Artificial Superintelligence (BASI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505282917/en/ K Navigator home screen. A single natural language interface - K Navigator enables users to explore and visualize data, refine questions, and uncover insights with ease. It accelerates literature reviews across 26.5 million scientific articles, reveals unexplored and unpublished research areas, and delivers more accurate analysis, drawing on 19 biomedical databases featuring thousands of patients. Exclusive access to cutting-edge spatial tra
NIKE, Inc. Announces Senior Leadership Changes to Accelerate Growth and Drive Win Now Action Plan5.5.2025 23:15:00 EEST | Press release
NIKE, Inc. (NYSE:NKE) announced a series of strategic changes to its Senior Leadership Team (SLT), elevating experienced leaders to accelerate progress against its Win Now action plan to position the company for future growth. Elliott Hill, President and CEO, NIKE, Inc. and Heidi O’Neill, President of Consumer, Product, and Brand, have decided the Consumer, Product, and Brand leadership will now be divided into three distinct areas: Consumer and Sport, Marketing, and Product Creation, inclusive of Innovation and Design. These roles will now report directly to Hill. As a result of these changes O’Neill has decided to retire from Nike after 26 years. She will continue to serve in an advisory capacity until September 2025. “For nearly three decades, Heidi has been a true champion for Nike, for sport and for athletes across the globe. Her vision and dedication over the years have left an indelible mark on Nike and created an impact on the world of sport,” said Hill. “Among Heidi’s many suc
LR Health & Beauty Once Again Demonstrates Its Expertise in Aloe Vera5.5.2025 17:24:00 EEST | Press release
LR Health & Beauty has been synonymous with the best Aloe Vera quality on the market for over 20 years, and continuously invests in new product innovations to take full advantage of the plant's range of beneficial properties. The majority of the over 60 products are developed and produced directly at the company headquarters in Ahlen. LR has now made a decisive breakthrough in skin care cosmetics with its unique combination of pure Aloe Vera leaf gel and fermented Aloe Vera. The care products with the highest Aloe Vera content therefore not only work in the upper and middle layers of the skin, but also unleash the full potential of Aloe Vera in the deeper layers. The effectiveness of this LR Aloe Via Magic Power Duo has been confirmed by the dermatological institute, Dermatest. All the products tested based on a combination of Aloe Vera Gel and fermented Aloe were awarded the 5-star "very good" seal by Dermatest. The test results* show increased moisture retention (up to 176%), improve
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom